HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.

AbstractBACKGROUND:
Inflammatory and hemostasis-related biomarkers may identify women at risk of stroke.
METHODS:
Hormones and Biomarkers Predicting Stroke is a study of ischemic stroke among postmenopausal women participating in the Women's Health Initiative observational study (n = 972 case-control pairs). A Biomarker Risk Score (BRS) was derived from levels of 7 inflammatory and hemostasis-related biomarkers that appeared individually to predict risk of ischemic stroke: C-reactive protein (CRP), interleukin-6, tissue plasminogen activator, D-dimer, white blood cell count, neopterin, and homocysteine. The c index was used to evaluate discrimination.
RESULTS:
Of all the individual biomarkers examined, CRP emerged as the only independent single predictor of ischemic stroke (adjusted odds ratio comparing Quartile(4)v Quartile(1) = 1.64, 95% confidence interval: 1.15-2.32, P = .01) after adjustment for other biomarkers and standard stroke risk factors. The BRS identified a gradient of increasing stroke risk with a greater number of elevated inflammatory/hemostasis biomarkers, and improved the c index significantly compared with standard stroke risk factors (P = .02). Among the subset of individuals who met current criteria for high-risk levels of CRP (>3.0 mg/L), the BRS defined an approximately 2-fold gradient of risk. We found no evidence for a relationship between stroke and levels of E-selectin, fibrinogen, tumor necrosis factor-alpha, vascular cell adhesion molecule-1, prothrombin fragment 1+2, Factor VIIC, or plasminogen activator inhibitor-1 antigen (P > .15).
DISCUSSION:
The findings support the further exploration of multiple biomarker panels to develop approaches for stratifying an individual's risk of stroke.
AuthorsRobert C Kaplan, Aileen P McGinn, Alison E Baird, Susan L Hendrix, Charles Kooperberg, John Lynch, Daniel M Rosenbaum, Karen C Johnson, Howard D Strickler, Sylvia Wassertheil-Smoller
JournalJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (J Stroke Cerebrovasc Dis) 2008 Nov-Dec Vol. 17 Issue 6 Pg. 344-55 ISSN: 1532-8511 [Electronic] United States
PMID18984425 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Biomarkers
  • Interleukin-6
  • Homocysteine
  • Neopterin
  • C-Reactive Protein
  • Tissue Plasminogen Activator
Topics
  • Aged
  • Biomarkers
  • C-Reactive Protein (analysis, metabolism)
  • Case-Control Studies
  • Comorbidity
  • Data Interpretation, Statistical
  • Female
  • Hemostatic Disorders (diagnosis, epidemiology)
  • Homocysteine (analysis, blood)
  • Humans
  • Incidence
  • Inflammation (diagnosis, epidemiology)
  • Interleukin-6 (analysis, blood)
  • Leukocyte Count
  • Middle Aged
  • Neopterin (analysis, blood)
  • Postmenopause (blood)
  • Predictive Value of Tests
  • Risk Factors
  • Stroke (diagnosis, epidemiology)
  • Tissue Plasminogen Activator (analysis, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: